A recent study indicates that people who stop using new slimming jabs like Mounjaro or Wegovy may regain lost weight much more quickly than those who halt traditional diet and exercise programs.
Findings released in a prominent health publication demonstrates that while overweight individuals often shed about a fifth of their body weight while undergoing treatment, the mass comes back at an average rate of 0.8 kg per month after stopping.
"People using such drugs need to be informed of the potential of rapid weight regain when the therapy is stopped," stated researcher Dr. Susan Jebb.
This pace of regain suggests a return to starting mass in about a year and a half.
Comparing Approaches
The research, which examined dozens of studies involving thousands of patients, compared the effects of these new drugs with other pills.
The team point out that individuals who shed pounds through diet and exercise generally see a more gradual creep back—perhaps 100 grams monthly—post-intervention.
Understanding the Rapid Regain
Experts suggest the mode of action of the drugs explains the accelerated weight return.
These medications imitate a natural hormone called glucagon-like peptide-1, which controls hunger.
"Artificially providing GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its endogenous GLP-1, and could diminish sensitivity to its actions," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this GLP-1 'fix' leads to hunger is no longer kept in check, making excessive eating far more likely."
A Chronic Issue?
Medical guidelines advise the injections for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
Professionals contend that, given the significant potential of weight regain, the treatment is often life-long.
This view is echoed by pharmaceutical companies, who say that the findings "underscore the long-term nature of obesity," similar to managing conditions like hypertension.
User Testimonies
Users who have come off the jabs report a sudden return of cravings.
"I experienced a switch that goes on and you become extremely hungry," recalled one woman.
This challenge is exacerbated if users have not established sustainable dietary or behavioural changes during therapy.
Widespread Interest
Figures suggest that millions of adults in the UK have tried these injections in the past year, with interest remaining high.
- Adoption is more common among females than men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than the NHS.
In conclusion, clinicians emphasize that while GLP-1 drugs are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits hinges on ongoing behavioural management.
